Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64

10/20/2026
Impact: 75
Healthcare

Piper Sandler analyst Matt O'Brien has reiterated an Overweight rating on HeartFlow (NASDAQ: HTFL) and increased the price target from $45 to $64. This adjustment reflects a positive outlook on the company's performance.

AI summary, not financial advice

Share: